Society guideline links: Testosterone therapy in men

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Male infertility or hypogonadism" and "Society guideline links: Male sexual dysfunction".)

International

●Endocrine Society (ES): Clinical practice guideline on testosterone therapy in men with hypogonadism (2018)

Canada

●Choosing Wisely Canada: Don’t order serum testosterone in men without symptoms of hypogonadism (updated 2020)

●Choosing Wisely Canada: Don’t prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency (updated 2020)

●Canadian Men's Health Foundation (CMHF): Diagnosis and management of testosterone deficiency syndrome in men – Clinical practice guideline (2015)

United States

●American Association of Clinical Endocrinology (AACE): Position statement on off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements – Risks and costs of a growing problem (2020)

●American Urological Association (AUA): Guidelines for the evaluation and management of testosterone deficiency (2018)

●US Food and Drug Administration (FDA): Testosterone information (updated 2015)

Europe

●European Association of Urology (EAU): Guidelines on sexual and reproductive health (2020, updated 2023)

●European Academy of Andrology (EAA): Guidelines on Klinefelter syndrome (2021)

●European Menopause and Andropause Society (EMAS): Position statement on testosterone replacement therapy in the aging male (2016)

United Kingdom

●Society for Endocrinology: Guidelines for testosterone replacement therapy in male hypogonadism (2021)

●British Society for Sexual Medicine (BSSM): Guidelines on adult testosterone deficiency, with statements for UK practice (2017)

India

●Integrated Diabetes and Endocrine Academy (IDEA): Consensus guideline on testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism (2021)

Australia–New Zealand

●Choosing Wisely Australia: Do not prescribe testosterone therapy to older men except in confirmed cases of hypogonadism

●Endocrine Society of Australia (ESA): Position statement on male hypogonadism (part 1) – Assessment and indications for testosterone therapy (2016)

●ESA: Position statement on male hypogonadism (part 2) – Treatment and therapeutic considerations (2016)

●Choosing Wisely Australia: Don't prescribe testosterone therapy unless there is evidence of proven testosterone deficiency (2015)

Japan

●[In Japanese] Japan Endocrine Society (JES) and Japan Men's Health Medical Association (JMHMA): Male hypogonadism guidelines (2022)

●[In English] The Japanese Urological Association (JUA)/Japanese Society for the Study of the Aging Male (JSSAM): Clinical practice manual for late-onset hypogonadism syndrome (2008)